GLP
FDA rules for nonclinical laboratory studies (21 CFR 58). Nonclinical safety studies submitted to FDA, such as many biocompatibility and animal studies, are expected to follow GLP or explain any deviation.
FDA rules for nonclinical laboratory studies (21 CFR 58). Nonclinical safety studies submitted to FDA, such as many biocompatibility and animal studies, are expected to follow GLP or explain any deviation.